The largest database of trusted experimental protocols
> Procedures > Diagnostic Procedure > Echo-Planar Imaging

Echo-Planar Imaging

Echo-Planar Imaging (EPI) is a rapid magnetic resonance imaging (MRI) technique that acquires multiple image slices in a single shot, allowing for fast data acquisition and decreased susceptibility to motion artifacts.
EPI is widely used in functional MRI (fMRI) studies to detect changes in blood oxygenation levels associated with neural activity.
This technique enables rapid, whole-brain coverage and is particuarly useful for studying dynamic brain processes.
EPI's high speed and sensitivity make it an invaluable tool for neuroscience research and clinical applications, such as the assessment of brain function and the diagnosis of various neurological disorders.

Most cited protocols related to «Echo-Planar Imaging»

Data on imported malaria patients in the Slovak Republic from 2003 to 2008 were obtained from the Epidemiological Information System of the Office of the Public Health of the Slovak Republic (EPIS). Analysis has evaluated costs during hospitalization. Patients without hospitalization were observed in home surroundings, this presents zero costs for hospitalization. From the data on hospitalized patients, it was calculated and estimated the direct cost to health insurance companies for the treatment of all patients. The costs of hospitalization were obtained from the health insurance companies and from the Health Care Surveillance Authority. The 2008 EUR exchange rate was used for cost calculations. The direct costs of hospitalization and of laboratory and imaging examinations were included.
Indirect costs included those to employers in the form of compensation for lost income to the health funds of the Social Insurance Company and health benefits as well as the production losses due to the reduction of the gross domestic product (GDP) during the patients' working disability. During adult patients' first ten days of working disability, their income is compensated by the employer at a rate of 25% of the daily-calculated basis for the first three days and then at a rate of 55% [1 ]. The lowest possible calculated daily base is defined as one-thirtieth of the minimum wage for workers with a monthly wage on the day on which the valid claim for compensation was made [2 ]. For calculation of indirect costs, the gross wages of employees were used. By law, in the Slovak Republic, there are guaranteed gross minimal wages. In calculating the costs, this was used as a base the minimum wage in 2008, which was 268.871 EUR monthly or 1.547 EUR hourly [3 ].
All group data were expressed as the mean and the standard deviation (SD). The costs incurred by patients without chemoprophylaxis were compared with those incurred by patients with chemoprophylaxis using the Mann-Whitney U test. A p value less than 0.05 was accepted as the level of statistical significance. Data were processed using the SPSS software Windows edition, version 11.0.
Publication 2012
Adult Chemoprevention Disabled Persons Echo-Planar Imaging Health Insurance Hospitalization Malaria Patients Physical Examination
All MR experiments were performed at room temperature on a 9.4T/31-cm magnet (Magnex, UK), interfaced to a Unity INOVA console (Varian). The actively shielded 12-cm-diameter gradient insert (Magnex, UK) operates at a maximum gradient strength of 40 gauss/cm and a rise time of 120 μs. A 3.8-cm-diameter volume coil (Rapid Biomedical, Ohio) was used for excitation and reception. Metabolite solution (see below) was transferred into a 9-mm I.D. syringe, and three or four syringes were inserted together into the coil for imaging. Magnetic field homogeneity was optimized by localized shimming over a ∼20 × 20 × 6 mm3 volume to yield a water spectral linewidth that was typically 10 Hz or less. The imaging parameters were: a field of view = 24 mm × 24 mm, matrix size = 64 × 64, and slice thickness = 5 mm. Before the SL and CEST experiments, a T1 map was obtained using an inversion-recovery sequence. In addition, the B1 field was also mapped for calibration of the transmit power (25 ). With our volume coil, the B1 map showed fairly good spatial homogeneity: the variation of B1 was less than 10% across all pixels within the samples (data not shown).
For SL and CEST experiments, the chemical exchange contrast was first generated by the SL or CEST preparation (Fig. 1A); then the residue magnetizations in the X-Y plane were dephased with crushing gradients; and finally, images were acquired with a spin-echo echo-planar imaging (EPI) technique using an echo time (TE) of 42 ms. For on-resonance R dispersion experiments, SL was either achieved with the sequence shown in Fig. 1A for Ω = 0 or with an adiabatic SL pulse sequence (25 ); the results were highly similar and are not distinguished here. R dispersion was measured for 10 ω1, SL values of approximately 1110, 1570, 2220, 3140, 4440, 6280, 8880, 12560, 17760, and 25120 rad/s. At each ω1, SL, 14 TSL values, ranging between 0 and 330 ms, were acquired with a repetition time (TR) of 8 s and a TE of 42 ms. For CEST and SL Z-spectra measurements, images were collected within ±10 ppm of the water resonance, with the Rabi frequency of a 4-s SL or CEST saturation pulse (ω1, SL or ω1, CEST) = ∼1100 rad/s, and the repetition time was 18 s. At each offset frequency, the SL flip angle θ was adjusted according to θ = arctan(ω1,SL / Ω). For the calculation of SLR and MTR, control M0 images were acquired at the offset frequencies of ±300 ppm.
Three sets of MRI phantom experiments were performed:
Publication 2010
Echo-Planar Imaging ECHO protocol Inversion, Chromosome Magnetic Fields Pulse Rate Syringes Vibration
The cross-sectional nature of the majority of studies examining adolescent neurocognitive functioning makes it difficult to determine the influence of alcohol and drug use on adolescent neurocognition. Therefore, ongoing longitudinal neuroimaging studies are essential to ascertain the degree to which substance intake is linked temporally to adverse changes on indices of brain integrity, or whether neural abnormalities reflect pre-existing patterns. In cross-sectional or longitudinal work, several methodological features are critical to evaluate the potential influence of adolescent substance use on neurocognition. These issues pertain to ensuring participant compliance, accurately assessing potential confounds, and maximizing participant follow-up.
Adolescent compliance as a research participant can be maximized by attending to rapport, building trust, and ensuring privacy of self-report data to the extent that is ethical and feasible to the setting. For behavioral tasks within or outside of imaging, it is critical to ensure participants comprehend task instructions, are fully trained on fMRI tasks, and then are given reminders just prior to task administration. Motion during scan acquisition is detrimental to the quality of imaging data, and is often worse in younger adolescents than older teens or adults. Adolescent head motion can be minimized by the following steps: discuss the importance and rationale for keeping the head still multiple times before and at the scan appointment; model and practice how to say “yes” and “no” when communicating with the research subject from the scanner; model and practice techniques for relaxing and ensuring subjects are in a position suitable for long-term comfort (e.g., legs are not crossed) before scanning begins; maximize participant comfort by using soft cushions around the head and under the knees; and many studies, especially those with younger participants, find practicing scanning in a less expensive mock scanner results in improved participant comfort and more reliable data during data acquisition.
Accurately measuring and accounting for confounds frequently present in adolescent substance-using populations is essential for elucidating the true effect of substance use on adolescent neurocognitive functioning. Common confounds in this population include head injury, depression, ADHD, conduct disorder, prenatal exposure to neurotoxins, family history-related effects, and polysubstance involvement. Conversely, excluding subjects for the aforementioned confounds may impede the generalizability of results. The tradeoff between minimizing confounds and having meaningful, ecologically valid results is an important study design decision, especially given the high cost of fMRI sessions.
Accurately measuring abstinence is another important consideration in substance-related research protocols. If abstinence is required for participation (and compensation) in a study, the dynamics of self-report could change. While biological data may help confirm self-report, these measures are imperfect and do not pinpoint the quantity of specific timing of substance intake 65 (link), 66 . Regarding abstinence from cannabis, obtaining serial quantitative THC metabolite levels, normalized to creatinine, is the best approach for guarding against new use episodes 67 .
Tracking participants over time is a critical part of many clinical issues when interested in the degree to which a variable (e.g., alcohol or marijuana use) might result in neural changes. Although some statistical approaches can help manage attrition, effective tracking procedures are more desirable to ensure study integrity. To maximize participant follow-up, frequent contact with participants must be maintained 68 . Having a well-trained, friendly staff experienced with the population also helps retain participants and parents, and ensures that all participants fully understand the tasks and expectations during the study. Collecting comprehensive contact information can help track adolescents over time in case they should relocate. Additionally, follow-up measures and procedures should be as similar as possible to baseline, except to mitigate learning and practice effects 69 (link). For imaging studies, field map unwarping of EPIs (e.g., fMRI and DTI) should also be considered, as this technique appears to produce more consistent localization of activations 70 (link). Finally, as technical problems are common, back up plans for each piece of equipment used in the neuroimaging session should be in place.
Publication 2009
Adolescent Adult Biopharmaceuticals Brain Cannabis Conduct Disorder Congenital Abnormality Craniocerebral Trauma Creatinine Disorder, Attention Deficit-Hyperactivity Echo-Planar Imaging Ethanol fMRI Head Infantile Neuroaxonal Dystrophy Knee Leg Marijuana Use Nervousness Neurotoxins Parent Pharmaceutical Preparations Substance Use Teens Tooth Attrition
SIU will achieve its aims through 4 primary study protocols (ATN 144 SMART: Sequential Multiple Assignment Randomized Trial; ATN 145 YMHP: Young Men’s Health Project; ATN 146 TMI: Tailored Motivational Interviewing Intervention; ATN 156 We Test: Couples' Communication and HIV Testing) [16 (link)-18 (link)], 2 center-wide protocols (ATN 153 EPIS and ATN 154 Cascade Monitoring; Carcone et al, under review, and Pennar et al, under review), and 3 cross-project initiatives. A substantial amount of literature underscores the importance of shortening the time from conceptualization of a research idea to service delivery. This concern has led to the development of effectiveness- implementation hybrid designs to facilitate the transition of promising interventions into practice [19 (link)]. Type 1 hybrid designs maintain a primary focus on a rigorous evaluation of the intervention but also gather data that will inform a subsequent implementation program. Type 2 hybrids place a dual focus on assessing the effectiveness of the intervention and evaluating the implementation strategy. Type 3 hybrid designs also focus on the implementation strategy and its effect of adaption and fidelity, but, in addition, assess patient-level or subject-level outcomes such as symptoms or disease progression [19 (link),20 (link)]. The 4 SIU primary study protocols include 2 Type 1 hybrids, 1 Type 2 hybrid, and 1 Type 3 hybrid. Two additional center-wide protocols measure contextual factors and cascade outcomes across the primary studies, and the 3 cross-project initiatives address cost-effectiveness, self-management constructs, and communication science within each protocol (Figure 1).
Publication 2019
Acclimatization Concept Formation Disease Progression Echo-Planar Imaging Hybrids Motivational Interviewing Muscle Rigidity Obstetric Delivery Patients Self-Management
The efflux pump inhibitor (EPI) carbonyl cyanide-chlorophenylhydrazone (CCCP; Sigma) was used to investigate the activity of the efflux pump in the tigecycline-resistant and tigecycline-susceptible K. pneumoniae isolates. The MICs of tigecycline were determined by the broth microdilution method in the presence and absence of CCCP (fixed concentration of 16 µg/mL). If the MIC values decreased 4-fold or greater in the presence of EPIs, this was defined as a significant inhibition effect [12] .
Publication 2014
Carbonyl Cyanide m-Chlorophenyl Hydrazone Echo-Planar Imaging Klebsiella pneumoniae mesoxalonitrile Psychological Inhibition Tigecycline

Most recents protocols related to «Echo-Planar Imaging»

MRI data were processed in SPM1251 . EPI images were slice-time corrected to the acquisition time of the middle slice and realigned to the mean EPI. High-quality T1 images were coregistered to the mean EPI image and segmented. The normalization parameters computed during the segmentation were used to normalize the gray matter segment (1 mm × 1 mm × 1 mm) and the EPIs (2 mm × 2 mm × 2mm) to the MNI templates. Finally, EPIs images were smoothed with a 6 mm kernel.
Publication 2023
Echo-Planar Imaging Gray Matter
We used the framework method to structure our qualitative analysis (Gale et al., 2013 (link);
J. Smith & Firth,
2011
) and thematic analysis as our methodological orientation
(Braun & Clarke, 2012). Coding was conducted using MAXQDA 2020 (MAXQDA 2020 ). To
characterize factors that affected clinical decision-making, we applied
deductive codes from the EPIS framework (Aarons et al., 2011 (link)) derived from a
list of EPIS factors and their definitions published in a recent systematic
review (Moullin et al.,
2019
). We coded for outer context factors (e.g., federal and
state Medicaid policy), inner-context factors (e.g., agency
characteristics), innovation or EBP factors (e.g., fit of the EBP within the
setting), and bridging factors (e.g., characteristics of external
consultants helping to support implementation). It was difficult to
characterize the stage of implementation (i.e., Exploration, Preparation,
Implementation, and Sustainment) for this project, as clinicians were
already implementing the EBP (though at a very low frequency). Furthermore,
the system had not yet determined whether they would use any implementation
strategies to support parent coaching use in the future. For this reason, we
decided it was most helpful to document EPIS factors that were involved in
the clinical decision-making process, rather than focusing on any specific
stage of implementation.
In addition to the 16 deductive codes, one additional inductive code was
used: logistical barriers (e.g., rural areas were difficult to access for
in-home parent coaching services during winter). The coders felt that these
logistical factors were not always better explained by existing deductive
codes. See Table 2 in Moullin et al., 2019 (link) for all codes and definitions.
Publication 2023
Echo-Planar Imaging Feelings Intrinsic Factor Parent Scabies Visit, Home
The research design used in JJ-TRIALS was a delayed-start (a.k.a., step wedge) randomized control trial, with county-level JJ agencies randomly assigned to an intervention condition using a Matched Block design (see Knight et al., 2016 (link)). Sites within a state were paired based on the number of youth aged 10–19 in the general population in the county and the total JJ caseload size; the pair were randomized to one of three start dates. The study was divided into discrete phases that were aligned with the EPIS model to monitor implementation achievements (Aarons et al., 2011 (link); Becan et al., 2020 (link)): Exploration (E; T1 Baseline), Preparation (P; T2 Pre-Randomization), Implementation (I; T3 Early Experiment, T4 Late Experiment), and Sustainment (S; T5 Maintenance). The baseline period (T1) lasted 9 to 18 months depending on the site; all other study phases were 6-months in duration. During the baseline period, de-identified youth records data related to the Cascade were collected. All JJ sites received the Core intervention (components described in the next section) during the Pre-randomization (T2) phase of the study. Prior to the 12-month experimental phase (T3 and T4), one of the sites within each pair was randomly assigned to the Enhanced intervention while the other remained a Core-only site that received standard technical assistance in response to questions, but otherwise no further assistance. The fifth and final phase of the study, the maintenance phase (T5), consisted only of data collection, including youth record extraction, staff surveys and focus groups with each site to determine whether sites sustained any new practices. All protocols were reviewed and approved by each research center’s Institutional Review Board and by state/local JJ agencies.
Publication 2023
Echo-Planar Imaging Ethics Committees, Research Youth
Measures that were included in this study were informed by the exploration, preparation, implementation and maintenance (EPIS) framework [24 (link)]. The EPIS framework highlights the importance of the relationship of the outer and inner contextual factors of organizations with implementation of evidence-based interventions. For our study, we wanted to assess which characteristics from SSPs’ outer and inner context were associated with levels of naloxone distribution. Our study outcomes included the number of naloxone doses distributed by the SSP in the prior 12 months as well as the number of people receiving naloxone from the SSP in the prior 12 months. Prior research has shown that increases in the number of people receiving naloxone and the number of naloxone doses distributed were significantly associated with reductions in opioid overdose mortality in the surrounding community [25 (link)–27 (link)].
Our exposure variables included measures from the outer and inner context of SSPs. With regard to the outer context, we asked each SSP about the legal status of their organization—whether they operated in a sanctioned or unsanctioned environment; and how they characterized levels of community support for their program on a scale of 0–100. Community support was dichotomized at the median of the distribution—a local community support rating of 80 out of 100—to allow for enough data to make a comparison and provide a meaningful cut-off point. To estimate the level of need in the surrounding community, we used the opioid overdose mortality rate in the counties where the SSP operated. Collected from the National Center for Health Statistics [5 ], these data were geocoded to the county level and matched to the county where each of the SSPs operated. If an SSP operated across multiple counties, the number of opioid overdose deaths and the population size were aggregated for all the counties in which they operated. Opioid overdose mortality rates were identified using ICD-10 codes X40–X44; X60–X64; X85; or Y10–Y14, where the multiple cause of death codes included T40.0, T40.1, T40.2, T40.3, T40.4 or T40.6. We created a 3-level ordered categorical variable of low (≤ 10), medium (> 10–< 18) and high (≥ 18), split at the tertile of the distribution.
With regard to the inner context, we asked each SSP how sustained their OEND implementations were by asking about number of years since they implemented OEND; whether the SSP regularly asked participants if they needed a naloxone refill (proactive) compared to waiting for participants to ask them for a refill (passive); and the number of days of service the SSP provides OEND to their participants in a typical 28-day (4 week) period.
Publication 2023
Echo-Planar Imaging Intrinsic Factor Naloxone Opiate Overdose Schopf-Schulz-Passarge Syndrome
A cross-sectional web-based survey will be administered to Medicaid/CHIP agency and MCO staff (i.e., MOUD benefit policymakers) to collect data on agency-level decision-making. Survey items will map to EPIS constructs to illuminate influences across outer and inner contexts. Survey items draw from existing reliable scales like the Implementation Leadership Scale [72 (link)], Purtle et al.’s Research Dissemination Barriers survey items [37 (link)], and the Six Factor Model of Evidence-based Decision-making Tool [73 (link)] to assess policymakers’ behaviors seeking, receiving, and using research. Survey items will inquire separately about the use of research when developing adult and youth MOUD benefits. Few scales assess outer context policy determinants [74 (link)], so we will develop items to collect data about these factors (e.g., need for legislative approval to alter benefits, partisanship, stigma) and intermediaries who share research. To reduce respondent burden, items quantifying MOUD benefit policies and state policy landscapes will be pre-filled using publicly available information from agency/MCO websites, contracts, and other policy documents.
Publication 2023
Adult DNA Chips Echo-Planar Imaging Youth

Top products related to «Echo-Planar Imaging»

Sourced in Germany, United States, United Kingdom, China
The Tim Trio is a versatile laboratory equipment that serves as a temperature-controlled magnetic stirrer. It features three independent stirring positions, allowing simultaneous operation of multiple samples. The device maintains a consistent temperature range to ensure accurate and reliable results during experimental procedures.
Sourced in United States, United Kingdom, Germany, Canada, Japan, Sweden, Austria, Morocco, Switzerland, Australia, Belgium, Italy, Netherlands, China, France, Denmark, Norway, Hungary, Malaysia, Israel, Finland, Spain
MATLAB is a high-performance programming language and numerical computing environment used for scientific and engineering calculations, data analysis, and visualization. It provides a comprehensive set of tools for solving complex mathematical and computational problems.
Sourced in United States, Germany, United Kingdom, Netherlands
The Discovery MR750 is a magnetic resonance imaging (MRI) system developed by GE Healthcare. It is designed to provide high-quality imaging for a variety of clinical applications.
Sourced in Netherlands, United States, Germany, India, Australia
The 32-channel head coil is a piece of laboratory equipment designed for magnetic resonance imaging (MRI) applications. It is used to transmit and receive radio frequency (RF) signals, which are essential for the image acquisition process in MRI scanners. The coil features 32 individual channels, allowing for improved signal-to-noise ratio and accelerated image acquisition times compared to traditional coil designs. This product is intended for use in research and clinical settings, where high-quality MRI data is required for various applications.
Sourced in United States, Netherlands, Germany
The Intera Achieva is a magnetic resonance imaging (MRI) system developed by Philips. It is designed to capture high-quality images of the human body for diagnostic and research purposes. The core function of the Intera Achieva is to generate detailed images of internal structures and processes using magnetic fields and radio waves.
Sourced in United States
H9 hESCs are a well-characterized line of human embryonic stem cells. They are derived from the inner cell mass of a pre-implantation human embryo and maintain the ability to differentiate into cells of all three germ layers.
Sourced in Germany, United States
The Prisma scanner is a high-performance medical imaging device designed for magnetic resonance imaging (MRI) applications. It features advanced hardware and software capabilities that enable efficient and reliable data acquisition for a wide range of clinical examinations.
Sourced in Germany, United States, Australia, United Kingdom, Canada
The 32-channel head coil is a key component in magnetic resonance imaging (MRI) systems. It is designed to acquire high-quality images of the human head, enabling detailed visualization and analysis of brain structure and function.
Sourced in Germany
The Magnetom Allegra is a magnetic resonance imaging (MRI) system developed by Siemens. It is designed to provide high-quality imaging for diagnostic and research applications. The Magnetom Allegra features a powerful magnetic field and advanced technology to capture detailed images of the human body.
Sourced in United States, Netherlands
The Ingenia 3.0T MR system is a magnetic resonance imaging (MRI) scanner produced by Philips. It operates at a magnetic field strength of 3.0 Tesla. The system is designed to capture high-resolution images of the human body for diagnostic and clinical applications.

More about "Echo-Planar Imaging"

Explore the power of Echo-Planar Imaging (EPI), a cutting-edge magnetic resonance imaging (MRI) technique that revolutionizes brain research and clinical applications.
EPI, also known as fast-scan MRI, enables rapid, whole-brain coverage by acquiring multiple image slices in a single shot, drastically reducing data acquisition time and minimizing motion artifacts.
Widely utilized in functional MRI (fMRI) studies, EPI is the go-to technique for detecting changes in blood oxygenation levels associated with neural activity, providing invaluable insights into dynamic brain processes.
This high-speed, highly sensitive imaging modality is an indispensable tool for neuroscience research, allowing researchers to delve into the inner workings of the brain with unprecedented temporal resolution.
Beyond research, EPI finds clinical applications in the assessment of brain function and the diagnosis of various neurological disorders.
Clinicians leverage the power of EPI-based MRI scans to gain a comprehensive understanding of the brain's structure and function, enabling early detection and effective management of conditions like stroke, trauma, and neurodegeneration.
To optimize your EPI workflows, explore the AI-driven protocol comparisons and comprehensive search and analysis tools offered by PubCompare.ai.
Discover the best protocols and products from literature, preprints, and patents, ensuring reproducible and accurate research.
Experience the transformative power of AI-assisted protocol optimization with platforms like Tim Trio, MATLAB, Discovery MR750, 32-channel head coil, Intera Achieva, H9 hESCs, Prisma scanner, Magnetom Allegra, and Ingenia 3.0T MR system.
Unlock the full potential of Echo-Planar Imaging and revolutionize your neuroimaging research and clinical practice today.